Literature DB >> 16804072

Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery.

Caterina Guidone1, Melania Manco, Elena Valera-Mora, Amerigo Iaconelli, Donatella Gniuli, Andrea Mari, Giuseppe Nanni, Marco Castagneto, Menotti Calvani, Geltrude Mingrone.   

Abstract

Currently, there are no data in the literature regarding the pathophysiological mechanisms involved in the rapid resolution of type 2 diabetes after bariatric surgery, which was reported as an additional benefit of the surgical treatment for morbid obesity. With this question in mind, insulin sensitivity, using euglycemic-hyperinsulinemic clamp, and insulin secretion, by the C-peptide deconvolution method after an oral glucose load, together with the circulating levels of intestinal incretins and adipocytokines, have been studied in 10 diabetic morbidly obese subjects before and shortly after biliopancreatic diversion (BPD) to avoid the weight loss interference. Diabetes disappeared 1 week after BPD, while insulin sensitivity (32.96 +/- 4.3 to 65.73 +/- 3.22 mumol . kg fat-free mass(-1) . min(-1) at 1 week and to 64.73 +/- 3.42 mumol . kg fat-free mass(-1) . min(-1) at 4 weeks; P < 0.0001) was fully normalized. Fasting insulin secretion rate (148.16 +/- 20.07 to 70.0.2 +/- 8.14 and 83.24 +/- 8.28 pmol/min per m(2); P < 0.01) and total insulin output (43.76 +/- 4.07 to 25.48 +/- 1.69 and 30.50 +/- 4.71 nmol/m(2); P < 0.05) dramatically decreased, while a significant improvement in beta-cell glucose sensitivity was observed. Both fasting and glucose-stimulated gastrointestinal polypeptide (13.40 +/- 1.99 to 6.58 +/- 1.72 pmol/l at 1 week and 5.83 +/- 0.80 pmol/l at 4 weeks) significantly (P < 0.001) decreased, while glucagon-like peptide 1 significantly increased (1.75 +/- 0.16 to 3.42 +/- 0.41 pmol/l at 1 week and 3.62 +/- 0.21 pmol/l at 4 weeks; P < 0.001). BPD determines a prompt reversibility of type 2 diabetes by normalizing peripheral insulin sensitivity and enhancing beta-cell sensitivity to glucose, these changes occurring very early after the operation. This operation may affect the enteroinsular axis function by diverting nutrients away from the proximal gastrointestinal tract and by delivering incompletely digested nutrients to the ileum.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16804072     DOI: 10.2337/db06-0068

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  125 in total

Review 1.  The neurohormonal regulation of energy intake in relation to bariatric surgery for obesity.

Authors:  Christopher N Ochner; Charlisa Gibson; Susan Carnell; Carl Dambkowski; Allan Geliebter
Journal:  Physiol Behav       Date:  2010-05-08

2.  First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis.

Authors:  N Basso; D Capoccia; M Rizzello; F Abbatini; P Mariani; C Maglio; F Coccia; G Borgonuovo; M L De Luca; R Asprino; G Alessandri; G Casella; F Leonetti
Journal:  Surg Endosc       Date:  2011-06-03       Impact factor: 4.584

Review 3.  Type 2 diabetes mellitus: a possible surgically reversible intestinal dysfunction.

Authors:  Priscila C Sala; Raquel S Torrinhas; Steven B Heymsfield; Dan L Waitzberg
Journal:  Obes Surg       Date:  2012-01       Impact factor: 4.129

4.  The preliminary clinical experience with laparoscopic duodenojejunal bypass for treatment of type 2 diabetes mellitus in non-morbidly obese patients: the 1-year result in a single institute.

Authors:  Kwang Yeol Paik; Wook Kim; Ki-Ho Song; Hyuk Sang Kwon; Mee Kyoung Kim; Eungkook Kim
Journal:  Surg Endosc       Date:  2012-06-08       Impact factor: 4.584

5.  The effect of duodenojejunal bypass for type 2 diabetes mellitus patients below body mass index 25 kg/m(2): one year follow-up.

Authors:  Yoonseok Heo; Jong-Hyuk Ahn; Seok-Hwan Shin; Yeon-Ji Lee
Journal:  J Korean Surg Soc       Date:  2013-08-26

6.  The effect of duodenal-jejunal bypass on glucose-dependent insulinotropic polypeptide secretion in Wistar rats.

Authors:  Tammy L Kindel; Stephanie M Yoder; David A D'Alessio; Patrick Tso
Journal:  Obes Surg       Date:  2010-02-23       Impact factor: 4.129

Review 7.  Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology.

Authors:  Guy Bower; Tania Toma; Leanne Harling; Long R Jiao; Evangelos Efthimiou; Ara Darzi; Thanos Athanasiou; Hutan Ashrafian
Journal:  Obes Surg       Date:  2015-12       Impact factor: 4.129

8.  Long-term control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic diversion in patients with BMI < 35 kg/m2.

Authors:  Nicola Scopinaro; Francesco Papadia; Giuseppe Marinari; Giovanni Camerini; Gianfranco Adami
Journal:  Obes Surg       Date:  2007-02       Impact factor: 4.129

9.  Twenty-four hour insulin secretion and beta cell NEFA oxidation in type 2 diabetic, morbidly obese patients before and after bariatric surgery.

Authors:  S Salinari; A Bertuzzi; A Iaconelli; M Manco; G Mingrone
Journal:  Diabetologia       Date:  2008-05-06       Impact factor: 10.122

10.  First-Phase Insulin and Amylin after Bariatric Surgery: A Prospective Randomized Trial on Patients with Insulin Resistance or Diabetes after Gastric Bypass or Sleeve Gastrectomy.

Authors:  Rahel Nussbaumer; Anne Christin Meyer-Gerspach; Ralph Peterli; Thomas Peters; Christoph Beglinger; Sonja Chiappetta; Juergen Drewe; Bettina Wölnerhanssen
Journal:  Obes Facts       Date:  2020-11-17       Impact factor: 3.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.